| Helvoet Pharma have recently invested €22 million in a new production unit, Paul Roosen at Helvoet Pharma discusses the company’s future with PMPS, along with the developments in pharmaceutical packaging technology
Helvoet Pharma, the pharmaceutical packaging division of the Daetwyler holding, is a leading manufacturer of rubber closures and aluminium caps for injectable drugs, medical devices and diagnostic systems. Helvoet Pharma has a global presence through its different production locations throughout the world. Helvoet Pharma has five rubbermanufacturing plants and four plants for the production of aluminium seals and flip caps in Europe and the US. Altogether, more than 12 billion components are supplied to a global customer base. This makes Helvoet Pharma a key worldwide supplier to the pharmaceutical, biotech, medical device and diagnostic market.
Why is Helvoet Pharma investing €22 million in a new production unit?
Over the last three years, there has been a distinct increase in demand for high-quality rubber components in the pharmaceutical packaging market. This has prompted the need not only for new and innovative product lines, but also for modified high-tech production environments that have to meet the increasingly strict standards set by the pharmaceutical industry. Moreover, large pharmaceutical companies today want their suppliers to uphold the same strict standards in their manufacturing processes as those applied in the pharmaceutical sector itself. Building this brand new production unit is Helvoet Pharma’s response to these stringent quality demands.
Which products will be manufactured in this new production unit? |
